º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Economic Development

Astrazeneca agrees to £12m payout to Bristol staff who lost jobs in u-turn move

The pharmaceutical giant has bowed to pressure from MPs and workers' union Unite

Astrazeneca sold its Avonmouth site in 2016(Image: PA)

Former workers at the old Astrazeneca site in Bristol , which collapsed less than two years after being sold off, will now receive full redundancy pay after the pharmaceutical giant bowed to pressure from MPs and workers’ union Unite .

Astrazeneca sold the Avonmouth site for £1 to pharmaceutical firm Avara Avalon in December 2016 and the 230-strong workforce were transferred as part of the deal. 

At the time, the workforce received a 'guarantee' that if the company went into administration within three years their enhanced redundancy rights would be protected and paid by AstraZeneca if needed.

Avara collapsed into administration in February this year but AstraZeneca initially failed to guarantee it would pay its former employees the enhanced redundancy payments, which amounted to £12million.

However, in a u-turn move today (Wednesday, July 17), AstraZeneca has confirmed that the company will pay out.

The cash will be placed into an independent fund and will be separate from other creditors.

A spokesperson for Astrazeneca said: “We have decided to set aside funding of up to £12million, to be administered independently, to make sure our former employees at the Avlon site receive full severance should the ongoing administration of the site not generate enough funds to cover redundancy costs.

“AstraZeneca remained closely involved in helping secure a future for the Avlon site following the sale to Avara, which was made in good faith in 2016.